Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Recruiting 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gastrointestinal 4Other neoplasm 1

Conditions

Gastrointestinal Neoplasms 1Gastrointestinal Malignancy 1Esophageal Neoplasms 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 229Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Electrocardiography, Ambulatory × Gastrointestinal × Clear all
NCT07456852 2026-06-02

Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy

Mayo Clinic

Phase 1/2 Recruiting
60 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

NCT06538610 2024-12-09

The 5-FU Holter Study

University of Auckland, New Zealand

Phase NA Recruiting
10 enrolled
Gastrointestinal

Gastrointestinal Malignancy

NCT04835987 2023-11-24

PROSNACO

Centre Hospitalier Universitaire de Saint Etienne

Withdrawn
Gastrointestinal

Esophageal Neoplasms

NCT04037319 2021-10-08

AFAR

Sheffield Teaching Hospitals NHS Foundation Trust

Unknown
720 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡